|
NEK7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.43405337289005E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.87389992412079E-10 |
| Normal-vs-Stage2 |
3.95110000273036E-09 |
| Normal-vs-Stage3 |
2.29800001250169E-09 |
| Normal-vs-Stage4 |
3.60170000002213E-06 |
| Stage1-vs-Stage2 |
1.767630E-01 |
| Stage1-vs-Stage3 |
5.627000E-01 |
| Stage1-vs-Stage4 |
8.044800E-01 |
| Stage2-vs-Stage3 |
3.942000E-01 |
| Stage2-vs-Stage4 |
4.120800E-01 |
| Stage3-vs-Stage4 |
8.766600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.23829884918814E-11 |
| Normal-vs-AfricanAmerican |
2.878800E-03 |
| Normal-vs-Asian |
8.82829999993007E-07 |
| Caucasian-vs-AfricanAmerican |
3.247400E-01 |
| Caucasian-vs-Asian |
8.459000E-01 |
| AfricanAmerican-vs-Asian |
3.502200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.61349997199289E-09 |
| Normal-vs-Female |
2.18810525254298E-11 |
| Male-vs-Female |
9.255800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.7832000037975E-08 |
| Normal-vs-Age(41-60Yrs) |
1.23057120049452E-12 |
| Normal-vs-Age(61-80Yrs) |
4.82330000384223E-08 |
| Normal-vs-Age(81-100Yrs) |
3.833800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.407700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.095800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.746200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.469800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.002200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.197200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.032200E-01 |
| Classical-VS-Follicular |
5.66100000000125E-05 |
| Classical-VS-Other |
2.088200E-01 |
| Classical-VS-Normal |
3.91600000204662E-08 |
| Tall-VS-Follicular |
2.375800E-01 |
| Tall-VS-Other |
4.766800E-01 |
| Tall-VS-Normal |
1.70860000003881E-06 |
| Follicular-VS-Other |
9.595800E-01 |
| Follicular-VS-Normal |
1.91735516352765E-12 |
| Other-VS-Normal |
1.539290E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.50350909079134E-14 |
| Normal-vs-N1 |
1.56819999985736E-07 |
| N0-vs-N1 |
5.803800E-01 |
|
|
